Sheldon Dray

5.0k total citations
182 papers, 4.1k citations indexed

About

Sheldon Dray is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sheldon Dray has authored 182 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 90 papers in Immunology and 64 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sheldon Dray's work include Monoclonal and Polyclonal Antibodies Research (63 papers), Glycosylation and Glycoproteins Research (46 papers) and Protein purification and stability (30 papers). Sheldon Dray is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (63 papers), Glycosylation and Glycoproteins Research (46 papers) and Protein purification and stability (30 papers). Sheldon Dray collaborates with scholars based in United States and Belgium. Sheldon Dray's co-authors include Glendowlyn O. Young, Margalit B. Mokyr, Rose G. Mage, Giuseppe A. Molinaro, Daniel E. Thor, Katherine L. Knight, Alfred Nisonoff, Ronald E. Paque, Alice Gilman‐Sachs and Marius Teodorescu and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Sheldon Dray

182 papers receiving 3.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sheldon Dray 2.0k 1.7k 1.1k 639 386 182 4.1k
Peter Ralph 2.6k 1.3× 2.4k 1.4× 692 0.6× 537 0.8× 466 1.2× 67 5.4k
Richard Asofsky 3.7k 1.8× 1.5k 0.9× 1.5k 1.4× 386 0.6× 470 1.2× 152 6.0k
Richard S. Metzgar 2.4k 1.2× 2.4k 1.4× 1.3k 1.2× 674 1.1× 366 0.9× 111 5.3k
Thomas J. Kindt 2.2k 1.1× 1.8k 1.0× 1.2k 1.1× 225 0.4× 498 1.3× 177 4.1k
Ira Green 4.2k 2.0× 1.2k 0.7× 1.2k 1.1× 380 0.6× 430 1.1× 121 6.6k
J W Uhr 3.5k 1.7× 1.6k 0.9× 1.6k 1.5× 226 0.4× 280 0.7× 111 5.0k
Norman R. Klinman 4.7k 2.3× 2.0k 1.2× 2.4k 2.2× 310 0.5× 486 1.3× 137 6.6k
G. G. B. Klaus 4.6k 2.3× 2.0k 1.2× 1.3k 1.2× 353 0.6× 337 0.9× 140 6.9k
E S Vitetta 4.1k 2.0× 1.5k 0.9× 1.6k 1.5× 379 0.6× 396 1.0× 122 5.6k
Paul H. Maurer 1.4k 0.7× 1.5k 0.9× 991 0.9× 200 0.3× 257 0.7× 214 3.6k

Countries citing papers authored by Sheldon Dray

Since Specialization
Citations

This map shows the geographic impact of Sheldon Dray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Dray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Dray more than expected).

Fields of papers citing papers by Sheldon Dray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon Dray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Dray. The network helps show where Sheldon Dray may publish in the future.

Co-authorship network of co-authors of Sheldon Dray

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon Dray. A scholar is included among the top collaborators of Sheldon Dray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon Dray. Sheldon Dray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mokyr, Margalit B., et al.. (1993). Cure of mice bearing a late-stage, highly metastatic, drug-resistant tumor by adoptive chemoimmunotherapy. Cancer Immunology Immunotherapy. 36(4). 229–236. 6 indexed citations
3.
Giacomoni, Dario, Feridoon Najmabadi, & Sheldon Dray. (1990). Serine Proteinase Inhibitors Produced by Human Melanoma Cell Lines. Tumor Biology. 11(1-2). 39–50. 1 indexed citations
4.
Giacomoni, Dario, Shlomo Ben‐Efraim, Feridoon Najmabadi, & Sheldon Dray. (1990). Inhibitors of lymphocyte activation secreted by human melanoma cell lines. Medical Oncology and Tumor Pharmacotherapy. 7(4). 273–80. 5 indexed citations
5.
Dray, Sheldon & Margalit B. Mokyr. (1989). Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy. Medical Oncology and Tumor Pharmacotherapy. 6(1). 77–85. 12 indexed citations
7.
Colvin, Michael, et al.. (1988). Tumoricidal and immunomodulatory activities of drugs and implications for therapy of mice bearing a late stage MOPC-315 plasmacytoma. International Journal of Immunopharmacology. 10(7). 825–834. 7 indexed citations
9.
Dray, Sheldon, et al.. (1979). Liposome-Mediated transfer of bacterial RNA into carrot protoplasts. Planta. 145(1). 37–44. 20 indexed citations
10.
Braun, Donald P., Margalit B. Mokyr, & Sheldon Dray. (1978). Generation of anti-MOPC-315 cytotoxicity in uneducated or in vitro educated spleen cells from normal or MOPC-315 tumor-bearing mice pretreated in vivo with Bacillus Calmette-Guérin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(6). 1626–32. 5 indexed citations
11.
Usher, David, et al.. (1978). Linkage between low-density lipoprotein and igk light-chain genes in rabbits. Immunogenetics. 7(1). 117–123. 3 indexed citations
12.
Braun, Donald P. & Sheldon Dray. (1977). Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(11). 4138–44. 6 indexed citations
13.
Knight, Katherine L., et al.. (1976). Heavy chain variable region allotypic sub-specificities of rabbit immunoglobulins. I. Identification of three subpopulations of a1 IgG molecules.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(1). 117–25. 31 indexed citations
14.
Teodorescu, Marius, Eugene P. Mayer, & Sheldon Dray. (1975). A simple radioimmunoassay for the enumeration of rosette-forming cells. Journal of Immunological Methods. 8(1-2). 127–132. 6 indexed citations
15.
Paque, Ronald E., Monte S. Meltzer, Berton Zbar, Herbert J. Rapp, & Sheldon Dray. (1973). Transfer of tumor-specific delayed hypersensitivity in vitro to normal guinea pig peritoneal exudate cells using RNA extracts from sensitized lymphoid tissues.. PubMed. 33(12). 3165–71. 15 indexed citations
16.
Dray, Sheldon, Michael Potter, & Rose Lieberman. (1965). Immunochemical and Genetic Studies of Two Distinct γG-Immunoglobulins in BALB/c Mice. The Journal of Immunology. 95(5). 823–833. 14 indexed citations
17.
Lichter, Edward A. & Sheldon Dray. (1964). Immunoelectrophoretic Characterization of Human Serum Proteins with Primate Antisera. The Journal of Immunology. 92(1). 91–99. 21 indexed citations
18.
Lieberman, Rose & Sheldon Dray. (1964). Five Allelic Genes at the Asa Locus Which Control γ-Globulin Allotypic Specificities in Mice. The Journal of Immunology. 93(4). 584–594. 14 indexed citations
19.
Harris, T. N., et al.. (1963). Shigella-: Rabbit Gamma-Globulin Allotypes as Genetic Markers for the Source of Antibody Produced in Recipients of* Incubated Lymph Node Cells*. Immunology. 6(2). 169. 11 indexed citations
20.
Dray, Sheldon, et al.. (1963). Immunochemical Identification and Genetics of Rabbit γ-Globulin Allotypes. The Journal of Immunology. 91(3). 403–415. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026